135 related articles for article (PubMed ID: 32109808)
1. Urine toxicology screen negative for Methadone metabolite but positive for Methadone in a patient on Methadone maintenance therapy (MMT).
Ravishankar DA; Calhoun E; Sethi R; Din A
Asian J Psychiatr; 2020 Apr; 50():101969. PubMed ID: 32109808
[No Abstract] [Full Text] [Related]
2. Influence of social network on drug use among clients of methadone maintenance treatment centers in Kunming, China.
Shen L; Assanangkornchai S; Liu W; Cai L; Li F; Tang S; Shen J; McNeil EB; Chongsuvivatwong V
PLoS One; 2018; 13(7):e0200105. PubMed ID: 29969481
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an implementation of methadone maintenance treatment in China.
Marienfeld C; Liu P; Wang X; Schottenfeld R; Zhou W; Chawarski MC
Drug Alcohol Depend; 2015 Dec; 157():60-7. PubMed ID: 26601934
[TBL] [Abstract][Full Text] [Related]
4. A pilot study to determine the usefulness of the urinary excretion of methadone and its primary metabolite (EDDP) as potential markers of compliance in methadone detoxification programs.
George S; Braithwaite RA
J Anal Toxicol; 1999; 23(2):81-5. PubMed ID: 10192409
[TBL] [Abstract][Full Text] [Related]
5. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
[TBL] [Abstract][Full Text] [Related]
6. Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study.
Mayet A; Lions C; Roux P; Mora M; Maradan G; Morel A; Michel L; Marimoutou C; Carrieri MP
J Subst Abuse Treat; 2015 Nov; 58():100-5. PubMed ID: 26260134
[TBL] [Abstract][Full Text] [Related]
7. Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing.
Taylor JR; Watson ID; Tames FJ; Lowe D
Addiction; 1998 Jun; 93(6):847-53. PubMed ID: 9744120
[TBL] [Abstract][Full Text] [Related]
8. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
Giacomuzzi SM; Ertl M; Kemmler G; Riemer Y; Vigl A
ScientificWorldJournal; 2005 May; 5():452-68. PubMed ID: 15925962
[TBL] [Abstract][Full Text] [Related]
9. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
Peles E; Schreiber S; Rados V; Adelson M
J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
[TBL] [Abstract][Full Text] [Related]
10. Role of ALDH5A1 in methadone treatment.
Torrens M; Fonseca F
Pharmacogenomics; 2014 Apr; 15(5):573-6. PubMed ID: 24798712
[No Abstract] [Full Text] [Related]
11. Relationship between methadone and EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) in urine samples from Norwegian prisons.
Bernard JP; Opdal MS; Karinen R; Mørland J; Khiabani HZ
Eur J Clin Pharmacol; 2007 Aug; 63(8):777-82. PubMed ID: 17576548
[TBL] [Abstract][Full Text] [Related]
12. Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study.
Ključević Ž; Benzon B; Ključević N; Veršić Bratinčević M; Sutlović D
Croat Med J; 2018 Dec; 59(6):298-306. PubMed ID: 30610772
[TBL] [Abstract][Full Text] [Related]
13. Methadone Medical Maintenance: An Early 21st-Century Perspective.
Novick DM; Salsitz EA; Joseph H; Kreek MJ
J Addict Dis; 2015; 34(2-3):226-37. PubMed ID: 26110221
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical trials for treatment of opiate dependence: what are the possibilities?
Jain RB
NIDA Res Monogr; 1992; 128():116-34; discussion 135-6. PubMed ID: 1436010
[No Abstract] [Full Text] [Related]
15. Characteristics and Outcome of Male and Female Methadone Maintenance Patients: MMT in Tel Aviv and Las Vegas.
Adelson M; Linzy S; Peles E
Subst Use Misuse; 2018 Jan; 53(2):230-238. PubMed ID: 28574738
[TBL] [Abstract][Full Text] [Related]
16. Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?
Koller G
Addiction; 2014 Apr; 109(4):608-9. PubMed ID: 24605959
[No Abstract] [Full Text] [Related]
17. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
[TBL] [Abstract][Full Text] [Related]
18. ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Farré M; Estivill X; Torrens M
Eur Neuropsychopharmacol; 2014 Mar; 24(3):420-4. PubMed ID: 24230997
[TBL] [Abstract][Full Text] [Related]
19. Integrative modeling of client engagement and outcomes during the first 6 months of methadone treatment.
Joe GW; Simpson DD; Greener JM; Rowan-Szal GA
Addict Behav; 1999; 24(5):649-59. PubMed ID: 10574302
[TBL] [Abstract][Full Text] [Related]
20. Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs.
Musshoff F; Trafkowski J; Lichtermann D; Madea B
Int J Legal Med; 2010 Sep; 124(5):499-503. PubMed ID: 19672612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
